Sakae Konishi
Papers
1
Total Citations
13
H-Index
1
About
Dr. Sakae Konishi is a pioneering urological researcher whose work centers on the development of novel biomarkers for surgical trauma and tissue damage assessment. His most significant contribution lies in demonstrating the clinical utility of total cell-free DNA (cfDNA) levels as a real-time, non-invasive indicator of surgical injury in urological procedures. In his landmark 2021 study, which has garnered 13 citations, Dr. Konishi established that perioperative cfDNA levels rise predictably in response to surgical trauma, offering a specific and quantifiable alternative to traditional, often inadequate, damage evaluation methods. This work addresses a critical gap in postoperative monitoring, where reliable biomarkers for tissue damage have been notably absent. By validating cfDNA as a dynamic measure of surgical stress, Dr. Konishi has opened new avenues for personalized recovery assessment and complication prediction in urological surgery. His research bridges molecular diagnostics and clinical urology, providing surgeons with a powerful tool to objectively gauge procedural impact and optimize patient care.
Research Focus
Key Achievements
Top Papers
- 1